Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis, 2021-2032
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.1.1 Factor affecting the value chain
3.1.2 Profit margin analysis
3.1.3 Disruptions
3.1.4 Future outlook
3.1.5 Manufacturers
3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Technological overview
3.5 Key news & initiatives
3.6 Regulatory landscape
3.7 Impact forces
3.7.1 Growth drivers
3.7.1.1 Increasing chronic pain conditions
3.7.1.2 Increasing consumer awareness
3.7.1.3 Growing sports participation trends
3.7.1.4 Advancements in treatment technology
3.7.2 Industry pitfalls & challenges
3.7.2.1 Skin sensitivity and adverse reactions
3.7.2.2 Regulatory compliance
3.8 Growth potential analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Market Estimates & Forecast, By Type, 2021-2032 (USD Million) (Thousand Units)
5.1 Key trends
5.2 Prescription patches
5.3 Over-the-counter patches
Chapter 6 Market Estimates & Forecast, By Application, 2021-2032 (USD Million) (Thousand Units)
6.1 Key trends
6.2 Muscle pain
6.3 Joint pain
6.4 Sports Injuries
6.5 Back pain
6.6 Minor aches and pains
Chapter 7 Market Estimates & Forecast, By Pack Size, 2021-2032 (USD Million) (Thousand Units)
7.1 Key trends
7.2 1 patch
7.3 2-5 patches
7.4 5-10 patches
7.5 More than 10 patches
Chapter 8 Market Estimates & Forecast, By Price Range, 2021-2032 (USD Million) (Thousand Units)
8.1 Key trends
8.2 Low
8.3 Mid
8.4 High
Chapter 9 Market Estimates & Forecast, By End-use, 2021-2032 (USD Million) (Thousand Units)
9.1 Key trends
9.2 Individual
9.3 Commercial
Chapter 10 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Million) (Thousand Units)
10.1 Key trends
10.2 Online
10.3 Offline
Chapter 11 Market Estimates & Forecast, By Region, 2021-2032 (USD Million) (Thousand Units)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 UK
11.3.2 Germany
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 India
11.4.3 Japan
11.4.4 South Korea
11.4.5 Australia
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 MEA
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 UAE
11.6.4 Rest of MEA
Chapter 12 Company Profiles
12.1 3M Health Care
12.2 Actavis
12.3 BioElectronics Corporation
12.4 Chattem, Inc.
12.5 Endo International plc
12.6 GlaxoSmithKline plc
12.7 Hisamitsu Pharmaceutical Co., Inc.
12.8 Johnson & Johnson
12.9 Mylan N.V.
12.10 Novartis AG
12.11 Pfizer Inc.
12.12 Reckitt Benckiser Group plc
12.13 Salonpas
12.14 Sanofi
12.15 Teva Pharmaceutical Industries Ltd.
